Home      About this journal      Authors      Referees      Editors      Readers      Archive      Contact us
Antihypertensive effects of Qinggan Tongluo yin in spontaneously hypertensive rats and protective effect on SHR heart
Hits 1725  Download times 1405  Received:March 24, 2018  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1673-9043.2018.05.14
Key Words   Qinggan Tongluo yin;Tianma Gouteng decoction;essential hypertension;professor XU Zongpei
Author NameAffiliationE-mail
SHA Zhengmei Tianjin University of Traditional Chinses Medicine, Tianjin 300193, China  
XU Zongpei Tianjin University of Traditional Chinses Medicine, Tianjin 300193, China  
LI Jinghao Tianjin University of Traditional Chinses Medicine, Tianjin 300193, China  
WANG Hongtao Tianjin University of Traditional Chinses Medicine, Tianjin 300193, China  
LI Lin TCM Resarch Institute, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
LIU Hong TCM Resarch Institute, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
LI Linwei Tianjin University of Traditional Chinses Medicine, Tianjin 300193, China  
YANG Pengfei Tianjin University of Traditional Chinses Medicine, Tianjin 300193, China  
LI Yuhong TCM Resarch Institute, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China yhltcm@126.com 
Abstract
    [Objective] Qinggan Tongluo yin(QGTLY) is a clinical experience based on professor XU Zongpei. To study the effects of QGTLY to spontaneously hypertensive rats (SHR) blood pressure, cardiac function and morphology, blood lipid.[Methods] By using SHR,measure blood pressure SBP on 1, 3, 4, 6 hours after the rat was tread with QGTLY one time, measure blood pressure SBP on 10 weeks after the rat was tread with QGTLY continuously. The indicators of left ventricular function and morphological structure were measured by small animal ultrasonic measuring instrument, such as LVEF, LVFS, Lvid, Ivs etc. Observe the changes of treated with QGTLY continuously on 10 weeks to study the effects on lipid.[Results] Treating with different dose group of QGTLY one time can not reduce the SBP of SHR. Treating with different dose group of QGTLY continuously 10 weeks. Treating with QGTLY[25 g/(kg·d)] redue the SBP of SHR at 1weeks, 5 weeks(P<0.05~0.01). Treating with QGTLY[6.25g/(kg·d)] reduce the SBP of SHR at 1 weeks, 7 weeks, 8 weeks(P<0.05). Treating with Valsartan one time or continuously 10 weeks can reduce the blood SBP(P<0.05~0.01). Different dose group of QGTLY can improve the EF, FS(P<0.05~0.01), reduce the left ventricular systole(P<0.05~0.01) and the end volume of the left ventricle(P<0.05~0.01), increase the interventricular septum thickness(P<0.01). There were no changes in lipids.[Conclusion] QGTLY can improve cardiac morphology, increase cardiac function, and reduce left ventricular hypertrophy on SHR.

You are the 1620307 visitor.

Copyright @ 2007
Address:   Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.